68 Ga-Trivehexin is an investigative PET radiopharmaceutical targeting the "cancer integrin" αvβ6, a tumor cell biomarker which is highly expressed by various carcinomas [1].Feasibility of targeting αvβ6-integrin for cancer imaging has been demonstrated in preclinical and first clinical
No takes yet. Share an insight, caveat, or question.
Rehm et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: